The Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 Years (opens original article in a new tab)

A promising ebola vaccine developed in 2011 has not been deployed or tested in humans despite its effectiveness in monkeys, due to lack of funding and interest, even as a new outbreak occurs.

• A 2011 study showed a vaccine protected monkeys from the Bundibugyo ebola strain, but it has not been tested in humans or deployed during the current outbreak.
• Funding and commercial interest have been lacking for the vaccine, despite its potential effectiveness and the World Health Organization's recognition of it as a promising candidate.
• The vaccine's development was delayed due to the strain's lower fatality rate and limited outbreaks, but recent efforts are underway to prepare it for human trials with $3.2 million in funding.